A detailed history of Affinity Asset Advisors, LLC transactions in Mesoblast LTD stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 400,000 shares of MESO stock, worth $3.27 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
400,000
Holding current value
$3.27 Million
% of portfolio
0.16%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.